Literature DB >> 32451614

Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment.

Neus Mongay-Ochoa1,2,3, Alberto Vogrig1,2, Sergio Muñiz-Castrillo1,2, Jerome Honnorat4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32451614     DOI： 10.1007/s00415-020-09940-y

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Epidemiology of paraneoplastic neurological syndromes: a population-based study.

Authors:  Alberto Vogrig; Gian Luigi Gigli; Samantha Segatti; Elisa Corazza; Alessandro Marini; Andrea Bernardini; Francesca Valent; Martina Fabris; Francesco Curcio; Francesco Brigo; Donatella Iacono; Paolo Passadore; Michele Rana; Jérôme Honnorat; Mariarosaria Valente
Journal:  J Neurol       Date:  2019-09-24       Impact factor: 4.849

Review 2.  Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors.

Authors:  Francesc Graus; Josep Dalmau
Journal:  Nat Rev Clin Oncol       Date:  2019-09       Impact factor: 66.675

3.  Nivolumab-induced Limbic Encephalitis with Anti-Hu Antibody in a Patient With Advanced Pleomorphic Carcinoma of the Lung.

Authors:  Hiroki Matsuoka; Hideharu Kimura; Hayato Koba; Yuichi Tambo; Noriyuki Ohkura; Johsuke Hara; Takashi Sone; Kazuo Kasahara
Journal:  Clin Lung Cancer       Date:  2018-05-05       Impact factor: 4.785

4.  CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model.

Authors:  Lidia M Yshii; Christina M Gebauer; Béatrice Pignolet; Emilie Mauré; Clémence Quériault; Mandy Pierau; Hiromitsu Saito; Noboru Suzuki; Monika Brunner-Weinzierl; Jan Bauer; Roland Liblau
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

5.  Central nervous system complications associated with immune checkpoint inhibitors.

Authors:  Alberto Vogrig; Sergio Muñiz-Castrillo; Bastien Joubert; Geraldine Picard; Veronique Rogemond; Cécile Marchal; Anne Marie Chiappa; Eve Chanson; François Skowron; Amelie Leblanc; François Ducray; Jerome Honnorat
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-04-20       Impact factor: 10.154

Review 6.  Neurologic complications of immune checkpoint inhibitors.

Authors:  Andreas F Hottinger
Journal:  Curr Opin Neurol       Date:  2016-12       Impact factor: 5.710

7.  Anti-Hu-Associated Autoimmune Limbic Encephalitis in a Patient with PD-1 Inhibitor-Responsive Myxoid Chondrosarcoma.

Authors:  Kyriakos P Papadopoulos; Rebecca S Romero; Gabriela Gonzalez; James E Dix; Israel Lowy; Matthew Fury
Journal:  Oncologist       Date:  2017-11-20
  7 in total
  6 in total

1.  How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update.

Authors:  Alberto Vogrig; Sergio Muñiz-Castrillo; Antonio Farina; Jérôme Honnorat; Bastien Joubert
Journal:  J Neurol       Date:  2021-10-27       Impact factor: 4.849

2.  Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature.

Authors:  Yining Gao; Jie Pan; Dingding Shen; Lisheng Peng; Zhifeng Mao; Chunxia Wang; Huanyu Meng; Qinming Zhou; Sheng Chen
Journal:  Brain Sci       Date:  2022-06-13

3.  Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature.

Authors:  Koki Nakashima; Yoshiki Demura; Kosuke Kurokawa; Toshihiro Takeda; Norihiro Jikuya; Masahiro Oi; Toshihiko Tada; Masaya Akai; Tamotsu Ishizuka
Journal:  Case Reports Immunol       Date:  2022-01-06

Review 4.  Drug-related immune-mediated myelopathies.

Authors:  David Gritsch; Cristina Valencia-Sanchez
Journal:  Front Neurol       Date:  2022-09-29       Impact factor: 4.086

Review 5.  Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis.

Authors:  John E Greenlee; Noel G Carlson; Justin R Abbatemarco; Ida Herdlevær; Stacey L Clardy; Christian A Vedeler
Journal:  Front Neurol       Date:  2022-01-17       Impact factor: 4.003

Review 6.  Paraneoplastic Autoimmune Neurological Syndromes and the Role of Immune Checkpoint Inhibitors.

Authors:  Sophie L Duong; Harald Prüss
Journal:  Neurotherapeutics       Date:  2022-01-18       Impact factor: 6.088
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.